Teleflex Incorporated (TFX) Balance Sheet

As reported in recent financial statements, Teleflex's total assets declined from $7.9 billion in 2025Q3 to $6.8 billion by 2026Q1, a contraction primarily driven by the strategic divestiture of the respiratory business and the subsequent reduction in the company's overall asset base and goodwill carrying values.

Based on the latest quarterly filings, Teleflex successfully reduced its total debt from a peak of $2.8 billion in 2025Q3 to $171.4 million in 2026Q1, resulting in a significantly improved debt-to-equity ratio of 0.06, which provides substantial headroom for future strategic capital allocation or potential acquisitions.

According to balance sheet data, goodwill remains a significant component of total assets at $2.3 billion as of 2026Q1, representing approximately 34% of the total asset base, which warrants close scrutiny regarding potential future impairment risks if the acquired interventional urology assets underperform current growth expectations.

As indicated by the reported financial figures, Teleflex maintained a current ratio of 2.55 in 2026Q1, reflecting a stable liquidity position that provides a sufficient buffer against short-term operational shocks despite the recent volatility in cash balances and the ongoing transition of the company's core business segments.

Based on the provided balance sheet data, total equity has remained relatively resilient at $3.1 billion in 2026Q1, despite the significant non-recurring charges and divestiture-related adjustments that have impacted the company's retained earnings and overall capital structure over the preceding ten quarters of financial reporting.